Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
Visa to Move European Headquarters to London’s Canary Wharf 
Spirit Airlines Reverses Pilot Furlough Plans Amid Updated Staffing Outlook 
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens 
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Waymo Issues Recall After Reports of Self-Driving Cars Illegally Passing School Buses in Texas 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Walmart Inc. is in discussions to acquire a significant stake in ChenMed LLC, marking a strategic push into the multi-billion-dollar U.S. healthcare sector. This potential acquisition underscores a broader retail trend of investing in health services, with ChenMed serving moderate-to-low-income seniors with chronic conditions.
The proposal is said to be Walmart’s largest venture in the healthcare sector. The company’s move to submit a proposal also comes at a time when a number of retailers are shoring up their presence in the health industry.
PYMNTS reported that sources who have knowledge of the matter revealed that Walmart and ChenMed are currently in talks for the stake acquisition. If the buyout proceeds, the value of the medical and technology company specializing in providing primary care is expected to reach several billion dollars.
The insiders added that if the deal pushes through, it could still take weeks to be confirmed. In addition, Walmart’s investment in ChenMed will also see it taking a stake in an organization that promotes itself as serving the neediest populations - the underserved, moderate-to-low-income seniors with complex chronic diseases.
As per The Sun US, the terms of the deal are not yet finalized; plus, the deal can also be abandoned. It is also possible that Walmart may not end up as the final buyer of ChenMed’s stake, but rather, other companies may secure the deal.
ChenMed is a family-owned business that Dr. Jen-Ling James Chen founded. He set up the business after being diagnosed with cancer. His diagnosis drove him and his family to explore the healthcare system.
After realizing that treatment is expensive and could be difficult to obtain, Chen decided to establish a company that can provide inexpensive care to patients. ChenMed was created to address financial risk for the cost of a patient’s medical needs, especially for seniors.
Photo by: Marques Thomas/Unsplash
